Logo of AJA Pharma
Saudi Chemical Holding Co.’s (SCCH) pharmaceutical arm, AJA Pharmaceutical Industries Co., has signed a non-binding memorandum of understanding (MoU) with Aldawaa Medical Services Co. (DMSCO) for the local manufacturing of some vital essential medicines necessitated by the Saudi market.
Under the MoU, both parties will jointly work towards long-term investment in transferring technology for such medicines, which are not being produced locally at present, Saudi Chemical said in a statement to Tadawul today, Oct. 21.
For more news on listed companies
This is to enhance the Kingdom’s self-sufficiency in this vital sector and ensure the continuous availability of these medicines.
The company also said that the MoU, running for six months and entailing no related parties, was signed on the sidelines of the 2024 Global Health Exhibition in Riyadh.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}